These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20333789)

  • 1. Wilson disease: histopathological correlations with treatment on follow-up liver biopsies.
    Cope-Yokoyama S; Finegold MJ; Sturniolo GC; Kim K; Mescoli C; Rugge M; Medici V
    World J Gastroenterol; 2010 Mar; 16(12):1487-94. PubMed ID: 20333789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience.
    Sini M; Sorbello O; Sanna F; Battolu F; Civolani A; Fanni D; Faa G; Demelia L
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):111-7. PubMed ID: 23011036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study.
    Marcellini M; Di Ciommo V; Callea F; Devito R; Comparcola D; Sartorelli MR; Carelli G; Nobili V
    J Lab Clin Med; 2005 Mar; 145(3):139-43. PubMed ID: 15871305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
    Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of a Liver Biopsy in the Management of Wilson Disease.
    Oe S; Honma Y; Yabuki K; Morino K; Kumamoto K; Hayashi T; Kusanaga M; Ogino N; Minami S; Shibata M; Abe S; Harada M
    Intern Med; 2020 Jan; 59(1):77-81. PubMed ID: 31511488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early occurrence of hypertransaminasemia in a 13-month-old child with Wilson disease.
    Iorio R; D'Ambrosi M; Mazzarella G; Varrella F; Vecchione R; Vegnente A
    J Pediatr Gastroenterol Nutr; 2003 May; 36(5):637-8. PubMed ID: 12717088
    [No Abstract]   [Full Text] [Related]  

  • 7. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
    Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
    J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
    Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
    Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse following withdrawal of D-penicillamine from combination (D-penicillamine + zinc) therapy in hepatic Wilson disease.
    Panda K; Lal BB; Sood V; Khanna R; Alam S
    J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1017-1026. PubMed ID: 38695602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 12. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
    Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C
    Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
    Dzieżyc K; Karliński M; Litwin T; Członkowska A
    Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to different therapeutic approaches in Wilson disease. A long-term follow up study.
    Rodríguez B; Burguera J; Berenguer M
    Ann Hepatol; 2012; 11(6):907-14. PubMed ID: 23109455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation on the changes of clinical symptoms, blood and brain copper deposition in Wilson disease patients treated with dimercaptosuccinic acid for 2 years.
    Zhou XX; Pu XY; Xiao X; Chen DB; Wu C; Li XH; Liang XL
    J Clin Neurosci; 2020 Nov; 81():448-454. PubMed ID: 33222961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation.
    Bruha R; Marecek Z; Pospisilova L; Nevsimalova S; Vitek L; Martasek P; Nevoral J; Petrtyl J; Urbanek P; Jiraskova A; Ferenci P
    Liver Int; 2011 Jan; 31(1):83-91. PubMed ID: 20958917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
    Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
    Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report: Co-occurrence of Wilson disease and oculocutaneous albinism in a Chinese patient.
    Rao R; Shu S; Han YZ; Chiu YJ; Han YS
    Medicine (Baltimore); 2018 Dec; 97(50):e13744. PubMed ID: 30558096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
    Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.